Skip to contentZ
Zivo Bioscience, Inc.
Z
ZIVOZivo Bioscience, Inc. Q3 2014 · 10-Q
Revenue$0.00$0.00— vs Q3 2013 Net Income-$3.34M-$3.34MN/M vs Q3 2013 EPS Diluted-$0.03-$0.03N/M vs Q3 2013 Operating Income-$1,096,442N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Zivo Bioscience, Inc. · CIK 1101026 · Engraved from SEC EDGAR
derived
ended Sep 30, 2014 · filed Nov 14, 2014 · 45 d after period end